SWX:CPHN

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

CPH Chemie + Papier Holding

Executive Summary

CPH Chemie + Papier Holding AG, together with its subsidiaries, develops, manufactures and distributes chemical products, paper, and pharmaceutical packaging films in Switzerland, rest of Europe, the Americas, Asia, and internationally.


Snowflake Analysis

Flawless balance sheet with proven track record.

Share Price & News

How has CPH Chemie + Papier Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CPHN has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-1.7%

CPHN

-1.7%

CH Forestry

0.5%

CH Market


1 Year Return

-19.9%

CPHN

2.3%

CH Forestry

-0.5%

CH Market

Return vs Industry: CPHN underperformed the Swiss Forestry industry which returned 2.9% over the past year.

Return vs Market: CPHN underperformed the Swiss Market which returned -0.5% over the past year.


Shareholder returns

CPHNIndustryMarket
7 Day-1.7%-1.7%0.5%
30 Day-9.9%-3.1%1.8%
90 Day-2.9%14.5%8.9%
1 Year-17.9%-19.9%4.9%2.3%2.8%-0.5%
3 Year45.1%37.7%7.6%-3.4%20.0%7.6%
5 Year74.7%61.0%73.3%8.1%35.2%12.6%

Price Volatility Vs. Market

How volatile is CPH Chemie + Papier Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CPH Chemie + Papier Holding undervalued compared to its fair value and its price relative to the market?

8.39x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CPHN (CHF67.6) is trading above our estimate of fair value (CHF67.06)

Significantly Below Fair Value: CPHN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CPHN is good value based on its PE Ratio (8.4x) compared to the Forestry industry average (10.8x).

PE vs Market: CPHN is good value based on its PE Ratio (8.4x) compared to the Swiss market (19.3x).


Price to Earnings Growth Ratio

PEG Ratio: CPHN's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: CPHN is good value based on its PB Ratio (0.9x) compared to the XE Forestry industry average (1x).


Next Steps

Future Growth

How is CPH Chemie + Papier Holding forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

-10.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CPHN's earnings are forecast to decline over the next 3 years (-10.9% per year).

Earnings vs Market: CPHN's earnings are forecast to decline over the next 3 years (-10.9% per year).

High Growth Earnings: CPHN's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CPHN's revenue (0.1% per year) is forecast to grow slower than the Swiss market (2.4% per year).

High Growth Revenue: CPHN's revenue (0.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CPHN's Return on Equity is forecast to be low in 3 years time (6.5%).


Next Steps

Past Performance

How has CPH Chemie + Papier Holding performed over the past 5 years?

64.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CPHN has high quality earnings.

Growing Profit Margin: CPHN's current net profit margins (9.2%) are higher than last year (7.9%).


Past Earnings Growth Analysis

Earnings Trend: CPHN has become profitable over the past 5 years, growing earnings by 64.3% per year.

Accelerating Growth: CPHN's earnings growth over the past year (14.3%) is below its 5-year average (64.3% per year).

Earnings vs Industry: CPHN earnings growth over the past year (14.3%) exceeded the Forestry industry -1.5%.


Return on Equity

High ROE: CPHN's Return on Equity (11%) is considered low.


Next Steps

Financial Health

How is CPH Chemie + Papier Holding's financial position?


Financial Position Analysis

Short Term Liabilities: CPHN's short term assets (CHF266.6M) exceed its short term liabilities (CHF95.9M).

Long Term Liabilities: CPHN's short term assets (CHF266.6M) exceed its long term liabilities (CHF165.5M).


Debt to Equity History and Analysis

Debt Level: CPHN's debt to equity ratio (27.7%) is considered satisfactory.

Reducing Debt: CPHN's debt to equity ratio has reduced from 34.1% to 27.7% over the past 5 years.

Debt Coverage: CPHN's debt is well covered by operating cash flow (49.9%).

Interest Coverage: CPHN's interest payments on its debt are well covered by EBIT (12.3x coverage).


Balance Sheet


Next Steps

Dividend

What is CPH Chemie + Papier Holding current dividend yield, its reliability and sustainability?

2.82%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CPHN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CPHN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CPHN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CPHN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: CPHN is not paying a notable dividend for the Swiss market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CPHN's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.5yrs

Average management tenure


CEO

Peter Schildknecht (58yo)

11.5yrs

Tenure

CHF955,000

Compensation

Dr. Peter Schildknecht has been Group Chief Executive Officer of CPH Chemie + Papier Holding AG since January 1, 2009. Mr. Schildknecht's professional career in industry began in 1995 at Von Roll, where he ...


CEO Compensation Analysis

Compensation vs Market: Peter's total compensation ($USD1.01M) is about average for companies of similar size in the Swiss market ($USD1.01M).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Peter Schildknecht
Group Chief Executive Officer11.5yrsCHF955.00k0.0033% CHF13.5k
Richard Unterhuber
Chief Financial Officer4.5yrsno data0.0042% CHF16.9k
Wolfgang Grimm
Head of Packaging Division17.5yrsno data0.0010% CHF4.1k
Alois Waldburg-Zeil
Head of the Chemistry Division10.5yrsno data0.0067% CHF27.1k
Klemens Gottstein
Head of Paper Division8.5yrsno datano data

10.5yrs

Average Tenure

58yo

Average Age

Experienced Management: CPHN's management team is seasoned and experienced (10.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Schaub
Chairman10yrsCHF339.00k0.0067% CHF27.1k
Kaspar Kelterborn
Director5.5yrsCHF122.00kno data
Tamer Talaat
Deputy Chairman4.67yrsCHF105.00k0.87% CHF3.5m
Mauro Gabella
Director15.17yrsCHF122.00kno data
Christian Wipf
Director12.25yrsCHF105.00k0.0067% CHF27.1k
Manuel Werder
Director5.5yrsCHF105.00k0.83% CHF3.4m

7.8yrs

Average Tenure

60yo

Average Age

Experienced Board: CPHN's board of directors are considered experienced (7.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CPH Chemie + Papier Holding AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CPH Chemie + Papier Holding AG
  • Ticker: CPHN
  • Exchange: SWX
  • Founded: 1818
  • Industry: Paper Products
  • Sector: Materials
  • Market Cap: CHF405.561m
  • Shares outstanding: 6.00m
  • Website: https://www.cph.ch

Number of Employees


Location

  • CPH Chemie + Papier Holding AG
  • Perlenring 1
  • Perlen
  • Root
  • Lucerne
  • 6035
  • Switzerland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CPHNSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFJun 2001
0QNZLSE (London Stock Exchange)YesRegistered SharesGBCHFJun 2001

Biography

CPH Chemie + Papier Holding AG, together with its subsidiaries, develops, manufactures and distributes chemical products, paper, and pharmaceutical packaging films in Switzerland, rest of Europe, the Americas, Asia, and internationally. It operates through three divisions: Chemistry, Paper, and Packaging. The Chemistry division provides molecular sieves for industrial applications; chromatography gels for the pharmaceuticals industry; and deuterated solvents for laboratory analysis use. This division offers its products under the Zeochem brand name. The Paper division produces newsprint and magazine paper products under the Perlen Papier brand. The Packaging division provides a range of PVC monofilms and coated PVdC barrier films under the Perlen Packaging brand name for use in the pharmaceuticals industry. The company was founded in 1818 and is based in Root, Switzerland. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/01 20:56
End of Day Share Price2020/07/01 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.